This new collection in Nanoscale focuses on the design of multifunctional hybrid nanomaterials for theranostics in biomedicine, with a focus on the scaling-up of these nanomaterials for translational studies. The scope of this collection loosely aligns with an accompanying symposium held at the 2023 Spring E-MRS meeting: Symposium J – Design and scaling up of theranostic nanoplatforms for health: towards translational studies, in Strasbourg, from 29 May – 2 June 2023. Potential topics include but are not limited to:
- Design, synthesis and characterization of nanoparticles: inorganic, polymers, liposomes, dendrimers
- Targeting strategies
- Multimodal Imaging (e.g., MRI, MPI, SPECT, PET)
- Multimodal therapy (e.g., hyperthermia, curie therapy)
- Drug delivery
- In vitro and in vivo validation of nanoplatforms combining multimodal imaging and therapies
- Scaling-up strategies of nanoplatform synthesis
- New synthesis processes taking into account good manufacturing practice (GMP) and environmental considerations
This call for papers is open for the following article types:
- Full papers
Open for submissions until 30 November 2023
If you would like to contribute to this themed collection, you can submit your article directly through the Nanoscale online submission system. Please mention that this submission is a contribution to the Theranostic nanoplatforms for biomedicine collection in the “Themed issues” section of the submission form and add a “Note to the Editor” that this is from the Open Call. The Editorial Office reserves the right to check suitability of submissions in relation to the scope of both the journal and the collection, and inclusion of accepted articles in the final themed issue is not guaranteed.
Please also note that all submissions will undergo our normal rigorous peer review processes including an initial assessment prior to peer review, and that peer review and acceptance are not guaranteed.